Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Structural Modification of Sylibin to Derivatives of Sylibin/Hydnocarpin D/Silandrin, and Evaluation of their Cytotoxicity against Cancer Cells.
Curr Top Med Chem. 2021;21(15):1398-1417. doi: 10.2174/1568026621666210701142826.
Curr Top Med Chem. 2021.
PMID: 34218782
Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Diabetes mellitus Predicted by 3D QSAR Pharmacophore Models, Molecular Docking and de novo Evolution.
Musoev A, Numonov S, You Z, Gao H.
Musoev A, et al.
Molecules. 2019 Aug 7;24(16):2870. doi: 10.3390/molecules24162870.
Molecules. 2019.
PMID: 31394858
Free PMC article.
Item in Clipboard
Cite
Cite